Deep Currents Investment Group LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $87.3 Million distributed in 346 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Western Digital Corp with a value of $8.64M, Spdr S&P 500 ETF Trust with a value of $7.99M, Trip.Com Group LTD with a value of $6.86M, Jazz Pharmaceuticals PLC with a value of $6.46M, and Jd.Com, Inc. with a value of $6.11M.
Examining the 13F form we can see an increase of $27.7M in the current position value, from $59.6M to 87.3M .
Deep Currents Investment Group LLC is based out at New York, NY
Below you can find more details about Deep Currents Investment Group LLC portfolio as well as his latest detailed transactions.
Portfolio value
$87.3 Million
$22.1 Million
$16.7 Million
$15.3 Million
$12.5 Million
$7 Million
$5.47 Million
$2.63 Million
$2.03 Million
$3.51 Million
Stock Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q1 2025
Added 7.58%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 53.57%
-
$0
0.0% of portfolio
-
Q1 2024
Added 11.92%
-
$0
0.0% of portfolio
-
Q1 2024
Added 31.15%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 10.75%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 83.75%
Apellis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.67%
-
$0
0.0% of portfolio
-
Q4 2023
Added 22.25%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 16.95%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 113.04%
-
$0
0.0% of portfolio
-
Q1 2025
Added 19.71%
-
$0
0.0% of portfolio
-
Q1 2025
Added 43.58%
-
$0
0.0% of portfolio
-
Q1 2025
Added 50.0%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 7.08%
-
$0
0.0% of portfolio
-
Q3 2024
Added 99.5%
Halozyme Therapeutics Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 25.45%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 19.05%
-
$0
0.0% of portfolio
-
Q1 2025
Added 8.8%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 34.92%
-
$0
0.0% of portfolio
-
Q4 2024
Added 18.23%
Integra Lifesciences Hldgs C
-
$0
0.0% of portfolio
-
Q4 2024
Added 307.46%
Ionis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q1 2025
Added 343.42%
Ironwood Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q1 2025
Added 6.0%
-
$0
0.0% of portfolio
-
Q1 2025
Added 14.95%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 9.56%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 95.08%
Dynavax Technologies Corp
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 7.72%
Envista Holdings Corporation
-
$0
0.0% of portfolio
-
Q3 2024
New
Esperion Therapeutics Inc Ne
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 91.2%
-
$0
0.0% of portfolio
-
Q1 2025
Added 5.52%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 19.09%
-
$0
0.0% of portfolio
-
Q3 2024
Added 51.4%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 6.7%
-
$0
0.0% of portfolio
-
Q1 2025
Added 20.57%
